0.02
—
Close of 9 Nov 2026, in AUD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About dorsaVi
Its shares trade on ASX under the ticker DVL.AX. It has been listed since 11 December 2013. In the fiscal year to 30 June 2026, it reported revenue of A$1.0m and a net loss of A$8.5m. At that date it held total assets of A$5.8m and shareholders' equity of A$4.3m.
dorsaVi Ltd. is a biotechnology company, which focuses on developing motion analysis device technologies for use in clinical practice, elite sports, and occupational health and safety. The company is headquartered in Melbourne, Victoria. The company went IPO on 2013-12-11. These technologies are commercialized through license, sale or fixed fee consultancy. The firm's segments include Australia, Europe and the United States of America. The firm's wireless technology consists of Muscle Sensor and Movement Sensor. The company offers wearable sensors, software and algorithms that objectively measure movement and muscle activation at over 200 frames per second. Its products include ViSafe, ViMove and ViPerform. ViSafe is a wireless sensor technology that tracks and measures how people move in real-time work situations. The company offers ViSafe Wearable Sensors and ViSafe Compliance. ViMove is a wireless sensor technology that objectively measures human movement and turns it into actionable data. ViPerform provides objective data to accurately assess and prevent risk of injury, guide training programs, and help determine when it is safe to return to play.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Biotechnology
- Listed since
- 11 Dec 2013
- Employees
- 34
- Website
- dorsavi.com ↗
Leadership
Pay as last reported
- Mr. Gernot AblNon-Executive Chairman of the Board
- Dr. Andrew RonchiChief Executive Officer, Executive Director, since 2008
- Mr. Aaron ChanChief Financial Officer
- Mr. John KowalczykPresident of Dorsavi US
- Mr. Daniel RonchiChief Technical Officer
- Mr. Dave WildermuthChief Marketing Officer
- Ms. Meagan BlackburnChief Innovation Officer
- Mark HeaysmanGroup OH&S Compliance Business Manager
- Mr. Matthew MayDirector National and Customer Relationships
- Ms. Sarah RiseleySenior Market Development lead, since 2014
- Dr. Muhammad UmerChief Product Officer, since 2014
- Ms. Zoe WhyattChief Operating Officer - Dorsavi Europe
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- dorsaVi Ltd possesses several strengths that contribute to its success in the market. These include:
Weaknesses
- Despite its strengths, dorsaVi Ltd also faces certain weaknesses that need to be addressed:
Opportunities
- There are several opportunities that dorsaVi Ltd can capitalize on to further expand its business:
Threats
- Despite its potential, dorsaVi Ltd faces certain threats that may impact its growth and profitability:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.